These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9219723)

  • 1. Western immunoblotting and enzymatic activity analysis of cathepsin D in human breast cancer cell lines of different invasive potential. Regulation by 17beta-estradiol, tamoxifen and ICI 182,780.
    Couissi D; Dubois V; Remacle C; Schonne E; Trouet A
    Clin Exp Metastasis; 1997 Jul; 15(4):349-60. PubMed ID: 9219723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells.
    Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H
    Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of insulin-like growth factor binding protein expression by ICI 182,780 in a tamoxifen-resistant human breast cancer cell line.
    Parisot JP; Leeding KS; Hu XF; DeLuise M; Zalcberg JR; Bach LA
    Breast Cancer Res Treat; 1999 Jun; 55(3):231-42. PubMed ID: 10517168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells.
    Abbas Abidi SM; Howard EW; Dmytryk JJ; Pento JT
    Clin Exp Metastasis; 1997 Jul; 15(4):432-9. PubMed ID: 9219732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cation-dependent mannose-6-phosphate receptor expression and distribution are influenced by estradiol in MCF-7 breast cancer cells.
    Bannoud N; Carvelli FL; Troncoso M; Sartor T; Vargas-Roig LM; Sosa M
    PLoS One; 2018; 13(8):e0201844. PubMed ID: 30086159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
    Xie S; Kang JX
    Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI
    J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estradiol stimulates cell growth and secretion of procathepsin D and a 120-kilodalton protein in the human ovarian cancer cell line BG-1.
    Galtier-Dereure F; Capony F; Maudelonde T; Rochefort H
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1497-502. PubMed ID: 1464654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human breast cancer cell lines resistant to pure anti-estrogens are sensitive to tamoxifen treatment.
    Lykkesfeldt AE; Larsen SS; Briand P
    Int J Cancer; 1995 May; 61(4):529-34. PubMed ID: 7759159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblasts capture cathepsin D secreted by breast cancer cells: possible role in the regulation of the invasive process.
    Heylen N; Vincent LM; Devos V; Dubois V; Remacle C; Trouet A
    Int J Oncol; 2002 Apr; 20(4):761-7. PubMed ID: 11894122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness.
    Larsen SS; Madsen MW; Jensen BL; Lykkesfeldt AE
    Int J Cancer; 1997 Sep; 72(6):1129-36. PubMed ID: 9378550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of antiestrogens on pS2 and cathepsin D mRNA induction in MCF-7 breast cancer cells.
    Rajah TT; Dunn ST; Pento JT
    Anticancer Res; 1996; 16(2):837-42. PubMed ID: 8687138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of antiestrogens on the release of plasminogen activator (uPA) by MDA-MB-231 and MCF-7 breast cancer cells.
    Abidi SM; Howard EW; Dmytryk JJ; Pento JT
    Clin Exp Metastasis; 1998 Apr; 16(3):235-41. PubMed ID: 9568641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased secretion of Cathepsin D in breast cancer in vivo by tamoxifen: mediated by the mannose-6-phosphate/IGF-II receptor?
    Dabrosin C; Johansson AC; Ollinger K
    Breast Cancer Res Treat; 2004 Jun; 85(3):229-38. PubMed ID: 15111761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160-kDa proteins in human breast cancer cells.
    Biegel L; Safe S
    J Steroid Biochem Mol Biol; 1990 Dec; 37(5):725-32. PubMed ID: 2278856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
    DeFriend DJ; Anderson E; Bell J; Wilks DP; West CM; Mansel RE; Howell A
    Br J Cancer; 1994 Aug; 70(2):204-11. PubMed ID: 8054267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of estrogen and antiestrogens on cell proliferation and synthesis of secreted proteins in the human breast cancer cell line MCF-7 and a tamoxifen resistant variant subline, AL-1.
    Lykkesfeldt AE; Sørensen EK
    Acta Oncol; 1992; 31(2):131-8. PubMed ID: 1622627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with the pure antiestrogen faslodex (ICI 182780) induces tumor necrosis factor receptor 1 (TNFR1) expression in MCF-7 breast cancer cells.
    Smolnikar K; Löffek S; Schulz T; Michna H; Diel P
    Breast Cancer Res Treat; 2000 Oct; 63(3):249-59. PubMed ID: 11110059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of a novel antiestrogen (Analog II) on human breast cancer cells.
    Jain PT; Rajah TT; Pento JT
    Anticancer Drugs; 1997 Nov; 8(10):964-73. PubMed ID: 9436640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.